acamprosate has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, R; Pan, J; Shen, M; Wu, R; Xu, S | 1 |
| Cesario, A; Leung, YK; Munschauer, FE; Pankewycz, O; Rittenhouse-Olson, K; Sobel, RA; Sternberg, DS; Sternberg, Z; Whitcomb, T; Zhu, B | 1 |
2 other study(ies) available for acamprosate and Innate Inflammatory Response
| Article | Year |
|---|---|
Acamprosate Protects Against Adjuvant-Induced Arthritis in Rats via Blocking the ERK/MAPK and NF-κB Signaling Pathway.
Topics: Acamprosate; Animals; Arthritis, Experimental; Inflammation; Male; MAP Kinase Signaling System; NF-kappa B; Osteoarthritis; Protective Agents; Rats; Rats, Wistar; Signal Transduction; Taurine | 2018 |
Acamprosate modulates experimental autoimmune encephalomyelitis.
Topics: Acamprosate; Animals; Blood-Brain Barrier; Body Weight; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Pilot Projects; Taurine; Tumor Necrosis Factor-alpha | 2012 |